A Study Evaluating the Activity of Anti-cancer Treatments Targeting Tumor Molecular Alterations/Characteristics in Advanced / Metastatic Tumors.
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Regorafenib
Related studies linked through entity extraction aliases.
Regorafenib in Bevacizumab Refractory Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Regorafenib and XELOX as 2nd Line Treatment in Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
An Investigational Immunotherapy Study of BMS-986288 Alone and in Combination With Nivolumab in Advanced Solid Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Immune Checkpoint Therapy vs Target Therapy in Reducing Serum HBsAg Levels in Patients With HBsAg+ Advanced Stage HCC
- Status
- RECRUITING
- Phase
- PHASE2
Zinc Supplement in Regorafenib Treated mCRC Patient
- Status
- COMPLETED
- Phase
- PHASE2
Regorafenib Plus FOLFIRI With Irinotecan Dose Escalated in Patients With Previously Treated Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial
- Status
- TERMINATED
- Phase
- PHASE1
Circulating Cell-Free Tumor DNA Testing in Guiding Treatment for Patients With Advanced or Metastatic Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Regorafenib in Taiwan Metastatic Colorectal Cancer (mCRC) Patients
- Status
- COMPLETED
- Phase
- N/A
Assessing a Regorafenib-irinotecan Combination Versus Regorafenib Alone in Metastatic Colorectal Cancer Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Phase II Study of Regorafenib as Maintenance Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Regorafenib and Nivolumab in Mismatch Repair (MMR) Refractory Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Metastatic Colorectal Cancer Treated With Regorafenib and FOLFIRI
- Status
- COMPLETED
- Phase
- NA
Regorafenib and Pembrolizumab in Treating Participants With Advanced or Metastatic Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Study Maintenance Regorafenib vs Placebo, no Progression Patients After I Line Chemotherapy Metastatic Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
QUILT 3.071: NANT Colorectal Cancer (CRC) Vaccine
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Metastatic Colorectal Cancer (Morpheus-CRC)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2